Circulating miRNA-770-5p and miRNA-30d-5p as potential biomarkers in vasoplegic syndrome after on-pump coronary artery bypass surgery - PREVENT trial

28 August 2022 (10:15 - 11:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Bianca Meneghini

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

6 More presentations in this session

Presentation thumbnail

Can carotid angioplasty stenting be better than endarterectomy or best medical treatment for patients with carotid stenosis?

Doctor R. Fernandes (Coimbra, PT)

Abstract Slides

Presentation thumbnail

Are severe mitral annular calcification still a contraindication to open surgery?

Doctor F. Petrini (Florence, IT)

Abstract Slides

Presentation thumbnail

Soluble urokinase plasminogen activator receptor predicts survival and hospitalization for heart failure in elective cardiac surgery

Doctor L. Koller (Vienna, AT)

Abstract Slides

Presentation thumbnail

Redo cardiac surgery in the era of percutaneous solutions: pattern of presentation and outcomes in a single tertiary care center

Doctor A. Montella (Naples, IT)

Abstract Slides

Presentation thumbnail

Thrombocytopenia following implantation of different types of bioprosthetic aortic valves in severe aortic valve stenosis replacement

Associate Professor K. LAMPROPOULOS (Athens, GR)

Abstract Slides

Access the full session

Session thumbnail

The broad spectrum of cardiovascular surgery

The Event

Event poster

ESC Congress 2022

28 August 2022 10:15 CET

You may be interested in

Congress Presentation

2024 ESC Guidelines on Chronic Coronary Syndromes: case presentation

Congress Presentation

Percutaneous coronary revascularisation in adult congenital heart disease

Congress Presentation

Abnormal origination of all coronary arteries from the right sinus of Valsalva

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources